IQVIA announced the unveiling of new custom-built AI agents at GTC Paris, designed to enhance workflows and accelerate insights for the life sciences and healthcare industries. These AI agents leverage NVIDIA technology, marking a significant advancement in IQVIA's artificial intelligence capabilities.
The new agentic architectures are live applications that demonstrate how IQVIA AI, combined with deep domain expertise, is transforming business processes and patient outcomes. Use cases for these offerings include target identification, clinical data review, literature review, market assessment, and HCP engagement.
This initiative is part of IQVIA's strategic collaboration with NVIDIA, which aims to accelerate the deployment of advanced agentic AI solutions. The company is utilizing NVIDIA NIM Agent Blueprints, NeMo Customizer, and NeMo Guardrails to develop agents that simplify operations and help find breakthroughs across life sciences.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.